Making Healthy Easier: Introducing Alternative Options for Type 2 Diabetes
LMC Manna Research is seeking volunteers who have Type 2 Diabetes to participate in a research study for an investigational medication that could lower blood sugars. Eligible participants must have Type 2 diabetes and heart disease (coronary artery disease, cerebrovascular disease, or peripheral artery disease).
Type 2 diabetes mellitus (T2DM) is a chronic disease that affects the body’s ability to use insulin. According to Diabetes Canada, there are 11 million Canadians living with diabetes or prediabetes. T2DM is associated with co-morbidities such as weight gain, hypertension, poor vision, excessive thirst, fatigue, and other complications in the body. Cardiovascular disease (heart disease) remains the leading cause of death and disability worldwide, with over 17 million people having had heart attacks or strokes in 2016 alone. A combination of diseases such as these creates a high risk of future adverse cardiovascular events, such as a heart attack or stroke. This is why it is so important that research studies like this be conducted. The ultimate goal is to find new treatment options for people with Type 2 Diabetes who pose high cardiovascular risk. This is an opportunity to possibly help advance medical knowledge that could lead to new treatment options for patients with T2DM and cardiovascular conditions.
This study may help researchers develop better treatments for individuals experiencing heart health issues with Type 2 Diabetes.
You may be eligible to participate if you are:
- Over the age of 40
- Have Type 2 Diabetes
- Have an existing heart health condition
You may be eligible to participate!
Reimbursement for time and travel may be available.
Call LMC Manna Research today!
LMC Manna Research